Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial. (Q46848022)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Erb-b2 receptor tyrosine kinase 2

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Mauro Giuseppe Mastropasqua

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

19

object named as

Giuseppe Viale

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Aron Goldhirsch

15

object named as

Aron Goldhirsch

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Meredith M Regan

2

object named as

Meredith M Regan

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

8

object named as

Karen N Price

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Monica Castiglione-Gertsch

14

object named as

Monica Castiglione-Gertsch

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Patrizia Dell'Orto

4

object named as

Patrizia Dell'Orto

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Stephen G Braye

11

object named as

Stephen Braye

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Barbara Del Curto

5

object named as

Barbara Del Curto

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Beat Thürlimann

17

object named as

Beat Thürlimann

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Birgitte B Rasmussen

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Anne E Lykkesfeldt

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Katrine L Henriksen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Magali Lacroix-Triki

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hans J Altermatt

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Richard D Gelber

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Barry A Gusterson

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alan S Coates

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

BIG 1-98 Collaborative and International Breast Cancer Study Groups

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

20 December 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

23-28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970386-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(07)70386-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083065%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46848022&oldid=1962328360"